Concurrent renal cell carcinoma and hematologic malignancies: Nine case reports

doi:10.5306/wjco.v11.i8.644

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5360)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

247

WORD

132

HTML

2033

Figures (1-1)

316

Tables (1-2)

180

Sum=2908

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

333

Download

582

Sum=915

Publishing Process of This Article

Item

Count

Browse

628

Download

909

Sum=1537

Aug 24, 2020 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Aug 24, 2020; 11(8): 644-654
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.644

Open in New Tab Full Size Figure Download Figure

Figure 1 Computed tomography imaging. A and B : Case #1: Computed tomography imaging revealed a renal mass (arrows). Biopsy of the mass was consistent with papillary renal cell carcinoma; C and D: The renal mass resolved after treating the follicular lymphoma with 6 cycles of bendamustine/rituximab (arrows).

Citation: Shields LB, Kalebasty AR. Concurrent renal cell carcinoma and hematologic malignancies: Nine case reports. World J Clin Oncol 2020; 11(8): 644-654
URL: https://www.wjgnet.com/2218-4333/full/v11/i8/644.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i8.644